Expression of bone morphogenetic proteins in the brain during normal aging and in 6-hydroxydopamine-lesioned animals

被引:56
作者
Chen, HL
Lein, PJ
Wang, JY
Gash, D
Hoffer, BJ
Chiang, YH
机构
[1] Natl Def Univ, Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan
[2] NIDA, NIH, Baltimore, MD 21224 USA
[3] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA
[4] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA
关键词
bone morphogenetic proteins; aging; substantia nigra; 6-hydroxydopamine;
D O I
10.1016/j.brainres.2003.09.020
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Bone morphogenetic proteins (BMPs), BMP receptors (BMPRs), and endogenous BMP antagonists have been found to be critically important for the development of the central nervous system (CNS) and peripheral organs in mammals. There is also increasing evidence that this system has significant activity in the adult CNS. Accordingly, we studied the regional distribution of endogenous BMP ligand proteins, receptors, and antagonists during aging and after lesion of the midbrain dopamine pathways produced by 6-hydroxydopamine (6-OHDA). We found that there were only small changes in the levels of these molecules as a function of age. Interestingly, levels of BMP 7 and noggin, a BMP antagonist, were uniquely elevated in substantia nigra. Moreover, after lesions of the midbrain dopamine system by 6-hydroxydopamine, there was a marked reduction in levels of all BMP ligands, receptors and antagonists bilaterally in both substantia nigra and hippocampus. There were also differential changes in BMP ligands, receptors, and antagonists in the cortex and striatum after such lesions. Taken together, our results indicate significant expression of BMP-related molecules in the adult and aging brain, and suggest a dynamic and differential regulation of these molecules after perturbations. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:81 / 90
页数:10
相关论文
共 63 条
[1]
Dendritic changes in Alzheimer's disease and factors that may underlie these changes [J].
Anderton, BH ;
Callahan, L ;
Coleman, P ;
Davies, P ;
Flood, D ;
Jicha, GA ;
Ohm, T ;
Weaver, C .
PROGRESS IN NEUROBIOLOGY, 1998, 55 (06) :595-609
[2]
BMPs as mediators of roof plate repulsion of commissural neurons [J].
Augsburger, A ;
Schuchardt, A ;
Hoskins, S ;
Dodd, J ;
Butler, S .
NEURON, 1999, 24 (01) :127-141
[3]
Backman C, 1996, J NEUROSCI, V16, P5437
[4]
AGING AND EXTRAPYRAMIDAL SYSTEM [J].
BARBEAU, A .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1973, 21 (04) :145-149
[5]
Bone morphogenetic proteins but not growth differentiation factors induce dopaminergic differentiation in mesencephalic precursors [J].
Brederlau, A ;
Faigle, R ;
Kaplan, P ;
Odin, P ;
Funa, K .
MOLECULAR AND CELLULAR NEUROSCIENCE, 2002, 21 (03) :367-378
[6]
Intravenous administration of bone morphogenetic protein-7 after ischemia improves motor function in stroke rats [J].
Chang, CF ;
Lin, SZ ;
Chiang, YH ;
Morales, M ;
Chou, J ;
Lein, P ;
Chen, HL ;
Hoffer, BJ ;
Wang, Y .
STROKE, 2003, 34 (02) :558-564
[7]
Distribution of bone morphogenetic protein and bone morphogenetic protein receptor transcripts in the rodent nervous system and up-regulation of bone morphogenetic protein receptor type II in hippocampal dentate gyrus in a rat model of global cerebral ischemia [J].
Charytoniuk, DA ;
Traiffort, E ;
Pinard, E ;
Issertial, O ;
Seylaz, J ;
Ruat, M .
NEUROSCIENCE, 2000, 100 (01) :33-43
[8]
Exposure of foetal mesencephalic cells to bone morphogenetic protein-2 enhances the survival of dopaminergic neurones in rat striatal grafts [J].
Espejo, M ;
Cutillas, B ;
Ventura, F ;
Ambrosio, S .
NEUROSCIENCE LETTERS, 1999, 275 (01) :13-16
[9]
CRITICAL ISSUES IN THE ANALYSIS OF DENDRITIC EXTENT IN AGING HUMANS, PRIMATES, AND RODENTS [J].
FLOOD, DG .
NEUROBIOLOGY OF AGING, 1993, 14 (06) :649-654
[10]
Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts [J].
Gazzerro, E ;
Gangji, V ;
Canalis, E .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (12) :2106-2114